Ionizing radiation-induced risks to the central nervous system and countermeasures in cellular and rodent models

E Pariset, S Malkani, E Cekanaviciute… - International Journal of …, 2021 - Taylor & Francis
Purpose Harmful effects of ionizing radiation on the Central Nervous System (CNS) are a
concerning outcome in the field of cancer radiotherapy and form a major risk for deep space …

Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's …

M Zhang, Z Zhang, H Li, Y Xia, M Xing, C Xiao… - Translational …, 2024 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative disorder and the predominant
type of dementia worldwide. It is characterized by the progressive and irreversible decline of …

Distinguishing Tumor Admixed in a Radiation Necrosis (RN) Background: 1H and 2H MR With a Novel Mouse Brain-Tumor/RN Model

X Ge, KH Song, JA Engelbach, L Yuan, F Gao… - Frontiers in …, 2022 - frontiersin.org
Purpose Distinguishing radiation necrosis (RN) from recurrent tumor remains a vexing
clinical problem with important health-care consequences for neuro-oncology patients …

Determinants of cerebral radionecrosis in animal models: A systematic review

S Al-Rubaiey, C Senger, J Bukatz, K Krantchev… - Radiotherapy and …, 2024 - Elsevier
Background Radionecrosis is a common complication in radiation oncology, while
mechanisms and risk factors have yet to be fully explored. We therefore conducted a …

Animal models of brain metastasis

L Miarka, M Valiente - Neuro-Oncology Advances, 2021 - academic.oup.com
Modeling of metastatic disease in animal models is a critical resource to study the
complexity of this multi-step process in a relevant system. Available models of metastatic …

Can low‐dose intravenous bevacizumab be as effective as high‐dose bevacizumab for cerebral radiation necrosis?

M Gao, X Wang, X Wang, G Niu, X Liu, S Zhao… - Cancer …, 2024 - Wiley Online Library
Although intravenous bevacizumab (IVBEV) is the most promising treatment for cerebral
radiation necrosis (CRN), there is no conclusion on the optimal dosage. Our retrospective …

Late effects of radiation prime the brain microenvironment for accelerated tumor growth

C Duan, R Yang, L Yuan, JA Engelbach… - International Journal of …, 2019 - Elsevier
Purpose Glioblastoma (GBM) remains incurable, despite state-of-the-art treatment involving
surgical resection, chemotherapy, and radiation. GBM invariably recurs as a highly invasive …

Inhibitors of HIF-1α and CXCR4 mitigate the development of radiation necrosis in mouse brain

R Yang, C Duan, L Yuan, JA Engelbach… - International Journal of …, 2018 - Elsevier
Purpose There is mounting evidence that, in addition to angiogenesis, hypoxia-induced
inflammation via the hypoxia-inducible factor 1α (HIF-1α)–CXC chemokine receptor 4 …

Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis

R Bodensohn, I Hadi, DF Fleischmann… - Strahlentherapie und …, 2020 - Springer
Background and purpose Radiation necrosis is a possible adverse event after cranial
radiation therapy and can cause severe symptoms, such as an increased intracranial …

Irradiation-modulated murine brain microenvironment enhances GL261-tumor growth and inhibits Anti-PD-L1 immunotherapy

JR Garbow, TM Johanns, X Ge, JA Engelbach… - Frontiers in …, 2021 - frontiersin.org
Purpose Clinical evidence suggests radiation induces changes in the brain
microenvironment that affect subsequent response to treatment. This study investigates the …